SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-09-029034
Filing Date
2009-02-13
Accepted
2009-02-13 14:31:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 OMRIX BIOPHARMACEUTICALS, INC. dsc13ga.htm SC 13G/A 67140
3 GRAPHIC g89675img001.jpg GRAPHIC 8718
  Complete submission text file 0001193125-09-029034.txt   81230
Mailing Address 3333 WARRENVILLE ROAD SUITE 500 LISLE IL 60532
Business Address 3333 WARRENVILLE ROAD SUITE 500 LISLE IL 60532 6305772300
OBERWEIS ASSET MANAGEMENT INC/ (Filed by) CIK: 0000937886 (see all company filings)

IRS No.: 364106772 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 630 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10111
Business Address 630 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10111 (212) 887-6500
Omrix Biopharmaceuticals, Inc. (Subject) CIK: 0001349426 (see all company filings)

IRS No.: 522147005 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82558 | Film No.: 09601870
SIC: 2836 Biological Products, (No Diagnostic Substances)